Higher expression of Cx45 associated with the altered regulation of the mitogen-activated protein kinase (MAPK) pathway and the release of pro-inflammatory cytokines IL-17, TNFα, and IFNγ, resulted in a pro-tumorigenic environment and protected AML cells from chemotherapy. The gene discussed is GJC1; the disease is acute myeloid leukemia.